// App-Quantinova.ai

2076 : Albumin-linked proaerolysin based molecular grenades: A systemic therapeutic for disseminated castration resistant prostate cancer

Researchers

Presenter

  • Freddie L. Pruitt

Principal Investigators

  • Nathaniel Brennen

  • Lizamma Antony

  • David M. Rosen

  • Samuel Denmeade

  • John Isaacs

Medical Centers

  • Johns Hopkins University School of Medicine, Baltimore, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

  • Prostate cancer

  • Solid malignancies

Biomarkers

  • Prostate specific antigen

  • Human albumin

Drug/Treatment

  • Human serum albumin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved